Core Viewpoint - 康臣药业 has been actively repurchasing its shares, indicating a strategy to support its stock price amid recent declines [2] Share Buyback Summary - On October 23, 康臣药业 repurchased 422,000 shares at a price range of HKD 14.740 to HKD 15.040, totaling HKD 6.2941 million [2] - The stock closed at HKD 14.980 on the same day, reflecting a decrease of 2.73% with a total trading volume of HKD 26.6429 million [2] - Since October 14, the company has conducted buybacks for 8 consecutive days, acquiring a total of 2.011 million shares for a cumulative amount of HKD 30.7041 million, during which the stock price fell by 6.38% [2] - Year-to-date, 康臣药业 has completed 26 buyback transactions, repurchasing a total of 7.206 million shares for a total expenditure of HKD 89.2351 million [2] Detailed Buyback Data - The buyback details include various dates, number of shares repurchased, highest and lowest prices, and total amounts spent, showcasing a consistent buyback strategy [3]
康臣药业(01681.HK)连续8日回购，累计回购201.10万股